SAB Biotherapeutics, Inc.

SABS · XNAS

CIK 1833214fmd_0PHBBVGTE8TJ5FK7XNKNN963G7Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2020 to Sep 30, 2026, 24 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.